---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-008444"
form_type: "8-K"
ticker: "VCEL"
cik: "0000887359"
company_name: "Vericel Corp"
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T02:56:19.017519+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Vericel reports record Q4 gross margin 78%, FY2024 revenue up 20% to $237M, net income positive

## Summary
- Full-year 2024 revenue $237.2M (+20% YoY); MACI $197.3M (+20%), Burn Care $39.9M (+22%).
- Q4 GAAP net income $19.8M ($0.38 diluted EPS) vs $13.0M YoY; adjusted EBITDA margin 40%.
- FY2024 adjusted EBITDA $53.4M (23% margin), up 58% YoY; operating cash flow $58.2M.
- 2025 guidance: revenue growth 20-23%, gross margin 73-74%, adj. EBITDA margin 25-26%.
- MACI Arthro launch traction: ~250 surgeons trained; NexoBrid orders +42% QoQ; new facility on track.

## SEC filing metadata
- accession: 0001628280-25-008444
- form_type: 8-K
- ticker: VCEL
- cik: 0000887359
- company_name: Vericel Corp
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887359/000162828025008444/0001628280-25-008444-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887359/000162828025008444/vcel-20250227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-008444
- JSON: https://secwatch.observer/filing/0001628280-25-008444.json
- Plain text: https://secwatch.observer/filing/0001628280-25-008444.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.